Charles River Laboratories Schedules Fourth-Quarter and Full-Year 2012 Earnings Release and Conferen
Charles River Laboratories Schedules Fourth-Quarter and Full-Year 2012 Earnings Release and Conference Call
WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYS: CRL) will release fourth-quarter and full-year 2012 financial results on Wednesday, February 13th, after the market closes. A conference call has been scheduled to discuss this information on Thursday, February 14th, at 8:30 a.m. EST.
Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com. A replay will be accessible through the same website.
About Charles River
Accelerating Drug Development. Exactly. Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
Investor Relations Contact:
Charles River Laboratories International, Inc.
Susan E. Hardy, 781-222-6190
Corporate Vice President, Investor Relations
KEYWORDS: United States North America Massachusetts
The article Charles River Laboratories Schedules Fourth-Quarter and Full-Year 2012 Earnings Release and Conference Call originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.